Protein-Based Matrix Interferences in Ligand-Binding Assays
Authors:
- 1 April 2014
- journal article
- review article
- Published by Taylor & Francis in Bioanalysis
- Vol. 6 (8) , 1131-1140
Abstract
An adequate bioanalytical support for a typical biotherapeutic requires a number of assays, including those to measure drug concentration and to assess induction of specific immune responses. Ligand-binding assays are the most commonly used platform in bioanalysis of biotherapeutics. Ligand-binding assays are frequently designed to detect appropriate analytes in complex biological matrices with limited or no sample pretreatment steps. The complex composition of the test matrix is highly diverse and varies from normal to disease populations. Additional post-treatment changes are often observed, including induction of antidrug antibodies. Due to potential interaction of biological matrix components, for example, rheumatoid factors, heterophilic antibodies and human anti-animal antibodies, with the test analyte or assay reagents, ligand-binding assays are often subjected to various degrees of matrix interferences that lead to an erroneous under- or over-reporting of the analyte concentration. Impact of various matrix components and practical means designed to mitigate interferences are discussed in this Review.Keywords
This publication has 68 references indexed in Scilit:
- Anti‐Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefitsImmunology, 2013
- A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patientsSpringerPlus, 2013
- Rheumatoid Factor and Its Interference with Cytokine Measurements: Problems and SolutionsArthritis, 2011
- A novel method for quantitative measurement of a therapeutic monoclonal antibody in the presence of its target protein using enzymatic digestionJournal of Pharmaceutical and Biomedical Analysis, 2010
- Human IgG4 Binds to IgG4 and Conformationally Altered IgG1 via Fc-Fc InteractionsThe Journal of Immunology, 2009
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Anti‐cytokine autoantibodies are ubiquitous in healthy individualsFEBS Letters, 2007
- Rheumatoid factors in immune complexes of patients with rheumatoid arthritisSpringer Seminars in Immunopathology, 1988
- The Basic Components of the Immune SystemNew England Journal of Medicine, 1987